Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma

Published:2009-04-24 Issue:3 Volume:56 Page:163-167
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Niitsu Nozomi,Umeda Masanori

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1996.tb01336.x/fullpdf

Reference18 articles.

1. MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma;Klimo;Ann Intern Med,1985

2. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma;Niitsu;Int J Hematol,1994

3. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;N Eng J Med,1993

4. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen;Laurence;Ann Intern Med,1982

5. Usefulness of the COP-BLAM regimen given with G-CSF in the treatment of intermediate and high grade non-Hodgkin's lymphoma;Niitsu;Jpn J Clin Hematol,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma;Leukemia;2003-01

2. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma;Leukemia Research;2002-03

3. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma;European Journal of Haematology;2002-02

4. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma;Blood;2001-03-01

5. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma;European Journal of Haematology;2001-01